What is the nature of Stephen J. Hemsley's transition?

Stephen J. Hemsley is transitioning from his management role as Executive Chair to a non-executive Director and Chair of the Board of UnitedHealth Group. He will no longer be involved in day-to-day management but will continue to provide strategic oversight and leadership at the board level.

How long has Stephen J. Hemsley been with UnitedHealth Group?

Mr. Hemsley has had a distinguished career with UnitedHealth Group spanning 22 years, including significant leadership roles such as Chief Executive Officer for ten years and Executive Chair for the past two years.

Will Stephen J. Hemsley receive any compensation for his new role?

Yes, Mr. Hemsley will receive standard director compensation as outlined in the company's proxy statement. Additionally, he will receive an annual cash retainer of $270,000 for his role as Chair, which will be pro-rated based on his actual service during the year.

What is the significance of this transition for investors?

This transition signifies a planned leadership evolution following a long tenure of a key executive. Investors may view this as a move towards succession planning and a continuation of experienced leadership at the board level, ensuring stability and ongoing guidance. The continued role of Mr. Hemsley as Chair suggests a smooth handover and ongoing strategic input.

UNH 8-K: Leadership Changes

Summary

UnitedHealth Group Inc. (UNH) announced a significant leadership transition involving its former executive chair, Stephen J. Hemsley. Effective November 7, 2019, Mr. Hemsley will step down from his management role as executive chair but will continue to serve the company as a non-executive director and as Chair of the Board. This move marks the end of an extensive 22-year tenure with the company, during which he held key leadership positions, including CEO for ten years. His continued involvement as Chair signifies a commitment to ongoing guidance and stability at the board level.

Key Highlights

1Stephen J. Hemsley transitions from Executive Chair to non-executive Director and Chair of the Board, effective November 7, 2019.
2Mr. Hemsley's transition concludes a 22-year career with UnitedHealth Group, including 10 years as CEO and 2 years as Executive Chair.
3Mr. Hemsley will continue to serve as Chair of the Board in a non-executive capacity.
4Richard T. Burke remains the Lead Independent Director.
5Mr. Hemsley will receive director compensation and an additional annual cash retainer of $270,000 for his role as Chair, pro-rated for service.
6The transition is framed as a planned management succession after a long and impactful career.

UNITEDHEALTH GROUP INC 8-K Report, Executive Changes (Nov 8, 2019)

Summary

Key Highlights

Frequently Asked Questions